申请人:Novartis AG
公开号:US20190062309A1
公开(公告)日:2019-02-28
The present disclosure provides a compound of Formula (I′):
or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R
1
, R
2
, R
x
, X
1
, n, n1, and q are as defined herein, and methods of making and using same.
本公开提供化合物的化学式(I′):或其药用可接受的盐、水合物、溶剂合物、前药、立体异构体或互变异构体,其中R1、R2、Rx、X1、n、n1和q如本文所定义,并提供制备和使用该化合物的方法。